Literature DB >> 12470482

Selection and characterization of human antibodies against hepatitis B virus surface antigen (HBsAg) by phage-display.

Se-Ho Kim1, Song-Yong Park.   

Abstract

Hepatitis B virus (HBV) is one of the main pathogens of hepatitis and hepatocarcinoma. Human plasma-derived antibody to HBV is being used as a prophylactic for postexposure to HBV and liver transplantation currently. However, it is required to replace the plasma-derived anti-HBs antibody (Ab) to a recombinant antibody because of limited availability of human plasma with high anti-HBs Ab titer and possible contamination of human pathogens. We constructed an anti-HBs Ab-enriched phage-display library from peripheral blood B cells of vaccinated volunteers and the size of library was approximately 1.0 x 10(7). The library was panned against hepatitis B surface antigen (HBsAg) and five different clones were isolated. All five clones exhibited the same heavy chain sequence; in contrast, light-chain exhibited one lambda and four different kappa sequences. The Fabs were expressed soluble in E. coli and exhibited affinities of 2.1 x 10(8) approximately 7.7 x 10(8) M(-1).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12470482     DOI: 10.1089/153685902761022742

Source DB:  PubMed          Journal:  Hybrid Hybridomics        ISSN: 1536-8599


  10 in total

1.  Conversion of a murine monoclonal antibody A13 targeting epidermal growth factor receptor to a human monoclonal antibody by guided selection.

Authors:  Ki Hwan Chang; Min Soo Kim; Gwang Won Hong; Yong Nam Shin; Se Ho Kim
Journal:  Exp Mol Med       Date:  2012-01-31       Impact factor: 8.718

2.  A Combination of Human Broadly Neutralizing Antibodies against Hepatitis B Virus HBsAg with Distinct Epitopes Suppresses Escape Mutations.

Authors:  Qiao Wang; Eleftherios Michailidis; Yingpu Yu; Zijun Wang; Arlene M Hurley; Deena A Oren; Christian T Mayer; Anna Gazumyan; Zhenmi Liu; Yunjiao Zhou; Till Schoofs; Kai-Hui Yao; Jan P Nieke; Jianbo Wu; Qingling Jiang; Chenhui Zou; Mohanmmad Kabbani; Corrine Quirk; Thiago Oliveira; Kalsang Chhosphel; Qianqian Zhang; William M Schneider; Cyprien Jahan; Tianlei Ying; Jill Horowitz; Marina Caskey; Mila Jankovic; Davide F Robbiani; Yumei Wen; Ype P de Jong; Charles M Rice; Michel C Nussenzweig
Journal:  Cell Host Microbe       Date:  2020-06-05       Impact factor: 21.023

Review 3.  Phage display creates innovative applications to combat hepatitis B virus.

Authors:  Wen Siang Tan; Kok Lian Ho
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 4.  The growth and potential of human antiviral monoclonal antibody therapeutics.

Authors:  Wayne A Marasco; Jianhua Sui
Journal:  Nat Biotechnol       Date:  2007-12       Impact factor: 54.908

5.  A comprehensive analysis of filamentous phage display vectors for cytoplasmic proteins: an analysis with different fluorescent proteins.

Authors:  Nileena Velappan; Hugh E Fisher; Emanuele Pesavento; Leslie Chasteen; Sara D'Angelo; Csaba Kiss; Michelle Longmire; Peter Pavlik; Andrew R M Bradbury
Journal:  Nucleic Acids Res       Date:  2009-12-02       Impact factor: 16.971

6.  Affinity Maturation of an Epidermal Growth Factor Receptor Targeting Human Monoclonal Antibody ER414 by CDR Mutation.

Authors:  Ki-Hwan Chang; Min-Soo Kim; Gwang-Won Hong; Mi-Sun Seo; Yong-Nam Shin; Se-Ho Kim
Journal:  Immune Netw       Date:  2012-08-31       Impact factor: 6.303

7.  An E. coli-produced single-chain variable fragment (scFv) targeting hepatitis B virus surface protein potently inhibited virion secretion.

Authors:  Cheng Li; Yang Wang; Tiantian Liu; Matthias Niklasch; Ke Qiao; Sarah Durand; Li Chen; Mifang Liang; Thomas F Baumert; Shuping Tong; Michael Nassal; Yu-Mei Wen; Yong-Xiang Wang
Journal:  Antiviral Res       Date:  2018-12-30       Impact factor: 10.103

8.  mRNA display with library of even-distribution reveals cellular interactors of influenza virus NS1.

Authors:  Yushen Du; Judd F Hultquist; Quan Zhou; Anders Olson; Yenwen Tseng; Tian-Hao Zhang; Mengying Hong; Kejun Tang; Liubo Chen; Xiangzhi Meng; Michael J McGregor; Lei Dai; Danyang Gong; Laura Martin-Sancho; Sumit Chanda; Xinming Li; Steve Bensenger; Nevan J Krogan; Ren Sun
Journal:  Nat Commun       Date:  2020-05-15       Impact factor: 14.919

9.  A New ELISA to Overcome the Pitfalls in Quantification of Recombinant Human Monoclonal Anti-HBs, GC1102, by Commercial Immunoassays.

Authors:  Yong Won Shin; Dong-Hyung Cho; Gi Won Song; Se-Ho Kim
Journal:  Biol Proced Online       Date:  2018-09-27       Impact factor: 3.244

Review 10.  Profiling the IgOme: meeting the challenge.

Authors:  Yael Weiss-Ottolenghi; Jonathan M Gershoni
Journal:  FEBS Lett       Date:  2013-11-12       Impact factor: 4.124

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.